fda glp-1 enforcement news today Targets Telehealth Compounded Marketing in New Warning Letters GLP-1 No Longer on FDA's

The very low rates of hypoglycemia are an additional advantage in vulnerable patients, such as the elderly or patients who live alone

These studies indicate that GLP-1 modulates the release of several neurotransmitters including serotonin, dopamine, GABA, and glutamate, which may regulate depressive-like behaviors

B12 is added to support energy, metabolism, and overall wellness

Providing support for a causal link between a negative energy state and increased Parasutterella abundance, a rat model of obesity, which showed similar Parasutterella relative abundances in animals maintained on HFD and those maintained on normal chow but exhibited a treatment-induced increase in Parasutterella relative abundance, displayed a negative correlation between Parasutterella and body weight 82